tradingkey.logo
tradingkey.logo
Suchen

ReShape Lifesciences Inc

RSLS
Zur Watchlist hinzufügen
3.920USD
0.0000.00%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
10.29MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über ReShape Lifesciences Inc Unternehmen

ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.

ReShape Lifesciences Inc Informationen

BörsenkürzelRSLS
Name des UnternehmensReShape Lifesciences Inc
IPO-datumOct 06, 2016
CEOMr. Paul F. Hickey
Anzahl der mitarbeiter17
WertpapierartOrdinary Share
GeschäftsjahresendeOct 06
Addresse1001 Calle Amanecer
StadtSAN CLEMENTE
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl92673
Telefon19494296680
Websitehttps://www.reshapelifesciences.com/obalon/
BörsenkürzelRSLS
IPO-datumOct 06, 2016
CEOMr. Paul F. Hickey

Führungskräfte von ReShape Lifesciences Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Krishna Gupta
Mr. Krishna Gupta
Chairman of the Board
Chairman of the Board
336.61K
--
Mr. Shiladitya Sengupta
Mr. Shiladitya Sengupta
Director
Director
92.00
--
Mr. Venkateswarlu (Venkat) Nelabhotla
Mr. Venkateswarlu (Venkat) Nelabhotla
Chief Executive Officer, Director
Chief Executive Officer, Director
8.00
+178.63%
Ms. Lori Courtney Mcdougal
Ms. Lori Courtney Mcdougal
Independent Director
Independent Director
--
--
Dr. Arda Minocherhomjee, Ph.D.
Dr. Arda Minocherhomjee, Ph.D.
Independent Director
Independent Director
--
--
Mr. Stash Pomichter
Mr. Stash Pomichter
Director
Director
--
--
Mr. John Tincoff
Mr. John Tincoff
Director
Director
--
--
Mr. Robert Dickey
Mr. Robert Dickey
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Mohanjit Jolly
Mr. Mohanjit Jolly
Director
Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Krishna Gupta
Mr. Krishna Gupta
Chairman of the Board
Chairman of the Board
336.61K
--
Mr. Shiladitya Sengupta
Mr. Shiladitya Sengupta
Director
Director
92.00
--
Mr. Venkateswarlu (Venkat) Nelabhotla
Mr. Venkateswarlu (Venkat) Nelabhotla
Chief Executive Officer, Director
Chief Executive Officer, Director
8.00
+178.63%
Ms. Lori Courtney Mcdougal
Ms. Lori Courtney Mcdougal
Independent Director
Independent Director
--
--
Dr. Arda Minocherhomjee, Ph.D.
Dr. Arda Minocherhomjee, Ph.D.
Independent Director
Independent Director
--
--
Mr. Stash Pomichter
Mr. Stash Pomichter
Director
Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von ReShape Lifesciences Inc?

Die fünf größten Anteilseigner von ReShape Lifesciences Inc sind: Mr. Krishna Gupta

Wie viele Institutionen halten Anteile an ReShape Lifesciences Inc (RSLS)?

Mit Stand vom 2026Q1 halten 34 Institutionen Anteile an ReShape Lifesciences Inc, mit einem Gesamtmarktwert von etwa 207.69K, was 2.96% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 148618.00 gestiegen.